Insulin-Like Growth Factor I Synergizes with Interleukin 4 for Hematopoietic Cell Proliferation Independent of Insulin Receptor Substrate Expression

ABSTRACT In the present study, we investigated the potential role of insulin-like growth factor I (IGF-I) receptor (IGF-IR) in cell proliferation by overexpressing it in 32D myeloid progenitor cells. The overexpression of IGF-IR caused the transfectants to proliferate in response to IGF-I in the absence of insulin receptor substrate (IRS) expression. The activation of overexpressed wild-type IGF-IR, but not that of an ATP-binding mutant of IGF-IR, resulted in the increased tyrosine phosphorylation of several intracellular proteins, including SHC, Src homology 2-containing inositol-5-phosphatase, protein kinase C-δ, and Erk2. Grb2 association with SHC and mitogen-activated protein kinase (MAPK) activity was also enhanced in response to IGF-I stimulation. Interestingly, the stimulation of the IGF-IR transfectants with interleukin 4 (IL-4) also resulted in strong mitogenesis independent of IRS expression. Moreover, IGF-I and/or IL-4 induced long-term cell growth of the IGF-IR transfectants. IL-4 was able to synergize with IGF-I for DNA synthesis, even in the parental 32D cells and a pro-B-cell line, Baf3, indicating the physiological importance of the two growth factors in hematopoietic cell proliferation. IL-4 stimulation of the IGF-IR transfectants resulted in enhanced tyrosine phosphorylation of SHC, Erk2, and signal transducer and activator of transcription 6 (STAT6) proteins. Both IL-4 and IGF-I were able to induce c-myc early response gene expression, and this expression was maximal in the presence of both factors. Finally, we demonstrated that a MAPK kinase inhibitor was able to suppress mitogenesis of the IGF-IR transfectants in response to IGF-I and/or IL-4. Together, our results suggest that IL-4 synergizes with IGF-I for hematopoietic cell proliferation, likely through cross talk between SHC/Grb2/MAPK and STAT6 pathways and through c-myc gene up-regulation.

[1]  L. Flechner,et al.  Protein Kinase C-δ Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation , 1998, Molecular and Cellular Biology.

[2]  Y. Matsuzawa,et al.  Insulin-like Growth Factor-I Augments Erythropoietin-induced Proliferation through Enhanced Tyrosine Phosphorylation of STAT5* , 1998, The Journal of Biological Chemistry.

[3]  T. Kurosaki,et al.  SHIP modulates immune receptor responses by regulating membrane association of Btk. , 1998, Immunity.

[4]  P. Gruppuso,et al.  Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation. , 1998, Endocrinology.

[5]  C. Conover,et al.  Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation. , 1998, Experimental cell research.

[6]  J. Pierce,et al.  Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[8]  R. Baserga,et al.  Co-operation of Simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by Interleukin-3 withdrawal , 1997, Oncogene.

[9]  M. Rubini,et al.  The IGF-I receptor in cell growth, transformation and apoptosis. , 1997, Biochimica et biophysica acta.

[10]  M. White,et al.  The insulin signalling system and the IRS proteins , 1997, Diabetologia.

[11]  T. Imamura,et al.  Functional Importance of Shc Tyrosine 317 on Insulin Signaling in Rat1 Fibroblasts Expressing Insulin Receptors* , 1997, The Journal of Biological Chemistry.

[12]  A. Sacchi,et al.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal , 1997, Molecular and cellular biology.

[13]  M. White,et al.  Insulin-induced egr-1 and c-fos Expression in 32D Cells Requires Insulin Receptor, Shc, and Mitogen-activated Protein Kinase, but Not Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Activation* , 1996, The Journal of Biological Chemistry.

[14]  J. Olefsky,et al.  Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. , 1996, Endocrinology.

[15]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB , 1996, Nature.

[16]  Ling-mei Wang,et al.  Stat6 and Jak1 Are Common Elements in Platelet-derived Growth Factor and Interleukin-4 Signal Transduction Pathways in NIH 3T3 Fibroblasts* , 1996, The Journal of Biological Chemistry.

[17]  H. Ha,et al.  Interleukin 4-induced proliferation in normal human keratinocytes is associated with c-myc gene expression and inhibited by genistein. , 1996, The Journal of investigative dermatology.

[18]  D. Le Roith,et al.  Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? , 1996, Cytokine & growth factor reviews.

[19]  J. Blenis,et al.  YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites , 1996, Molecular and cellular biology.

[20]  P G Pelicci,et al.  Not all Shc's roads lead to Ras. , 1996, Trends in biochemical sciences.

[21]  Ling-mei Wang,et al.  Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[22]  L. Rohrschneider,et al.  p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. , 1996, Genes & development.

[23]  J. Bertoglio,et al.  Interleukin-4 Induces Activation of Mitogen-activated Protein Kinase and Phosphorylation of Shc in Human Keratinocytes (*) , 1996, The Journal of Biological Chemistry.

[24]  P. Majerus,et al.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. S. Zong,et al.  Effect of Tyrosine Mutations on the Kinase Activity and Transforming Potential of an Oncogenic Human Insulin-like Growth Factor I Receptor (*) , 1996, The Journal of Biological Chemistry.

[26]  T. Gustafson,et al.  Distinct Modes of Interaction of SHC and Insulin Receptor Substrate-1 with the Insulin Receptor NPEY Region via Non-SH2 Domains (*) , 1995, The Journal of Biological Chemistry.

[27]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[28]  R. Baserga,et al.  Mutant IGF-I receptors as dominant negatives for growth and transformation. , 1995, Biochemical and biophysical research communications.

[29]  W. Paul,et al.  Interleukin 4 signals through two related pathways. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[31]  R. Baserga,et al.  The insulin-like growth factor I receptor: a key to tumor growth? , 1995, Cancer research.

[32]  D Mahadevan,et al.  Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling , 1994, The Journal of cell biology.

[33]  J. Pierce,et al.  Stimulation of the platelet-derived growth factor beta receptor signaling pathway activates protein kinase C-delta , 1994, Molecular and cellular biology.

[34]  T. O’Neill,et al.  Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.

[35]  W. Paul,et al.  Interleukin 4 receptor: signaling mechanisms. , 1994, Immunology today.

[36]  D. Bowtell,et al.  Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells , 1994, Molecular and cellular biology.

[37]  W. Paul,et al.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth , 1994, Cell.

[38]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[39]  H. Mischak,et al.  Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. , 1993, The Journal of biological chemistry.

[40]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[41]  Nanxin Li,et al.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.

[42]  G. Lienhard,et al.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Rutter,et al.  Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential , 1993, Journal of virology.

[44]  W. Rutter,et al.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence , 1992, Journal of virology.

[45]  S. Shurtleff,et al.  Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling , 1991, Nature.

[46]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[47]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[48]  T. S. P. S.,et al.  GROWTH , 1924, Nature.

[49]  M. White,et al.  The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. , 1998, Recent progress in hormone research.

[50]  W. Paul.  Interleukin 4: signalling mechanisms and control of T cell differentiation. , 1997, Ciba Foundation symposium.

[51]  J. Downward,et al.  Control of ras activation. , 1996, Cancer surveys.

[52]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. , 1996, Nature.

[53]  W. Paul,et al.  Signal transduction through the IL‐4 and insulin receptor families , 1995, Stem cells.